Traws Pharma
TRAW
TRAW
34 hedge funds and large institutions have $10.1M invested in Traws Pharma in 2021 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 8 increasing their positions, 7 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
9% less capital invested
Capital invested by funds: $11.1M → $10.1M (-$1M)
45% less call options, than puts
Call options by funds: $204K | Put options by funds: $368K
Holders
34
Holding in Top 10
–
Calls
$204K
Puts
$368K
Top Buyers
| 1 | +$958K | |
| 2 | +$922K | |
| 3 | +$687K | |
| 4 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$635K |
| 5 |
PVI
Pura Vida Investments
New York
|
+$575K |
Top Sellers
| 1 | -$248K | |
| 2 | -$231K | |
| 3 | -$184K | |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$169K |
| 5 |
Voloridge Investment Management
Jupiter,
Florida
|
-$140K |